Paeds · neurology-neurodisability-and-neuromuscular
Ataxia in children
Also known as Acute cerebellar ataxia · Childhood ataxia · Post-infectious cerebellar ataxia · Friedreich ataxia · Opsoclonus-myoclonus syndrome · Sensory ataxia · Cerebellar ataxia in children
Fellowship guide to ataxia in children: separating the common, benign post-infectious acute cerebellar ataxia from the dangerous posterior fossa tumour and the progressive hereditary causes such as Friedreich ataxia, the gait and bedside examination that localises cerebellar from sensory ataxia, the red-flag screen that drives urgent neuroimaging, and the genetic and multidisciplinary management of chronic progressive ataxia including omaveloxolone for Friedreich ataxia.
On this page & tools
Your progress
Saved locally on this device.
Practise this topic
Target exams
Red flags
Life stages
Care settings
Clinical exam formats
Board mappings
Overview & Definition
Picture the four-year-old who is brought to the emergency department walking as though drunk, feet wide apart and reeling, two weeks after a bout of chickenpox, and whose parents are terrified. That child carries the whole teaching point of paediatric ataxia: the unsteady gait is alarming to the family but is usually benign, the diagnosis is clinical, and the clinician's job is to confirm the safe, common pattern and to exclude the small minority that are dangerous. The decisive first question is not which drug to give but whether this is acute or chronic, and whether red flags are present, because that single distinction separates reassurance and observation from urgent imaging and oncology. [1] [2]
Ataxia is impaired coordination of voluntary movement that cannot be explained by weakness, sensory loss, or extrapyramidal rigidity alone. The lesion usually lies in the cerebellum or its connections, producing a wide-based, unsteady gait, dysmetria (past-pointing), intention tremor, dysdiadochokinesia (impaired rapid alternating movement), slurred speech, and nystagmus. A second, distinct mechanism is sensory ataxia, in which loss of proprioception from the dorsal columns deprives the brain of position sense, so the child walks unsteadily and falls in the dark and stamps the feet, with a positive Romberg sign. The clinician's first bedside task is to localise the ataxia to the cerebellum, to the sensory pathway, or to a vestibular cause, because the differential and the workup diverge from there. [1]
The framework that organises the whole topic is the acute-versus-chronic split combined with the red-flag screen. Acute ataxia, evolving over hours to days, is dominated by post-infectious acute cerebellar ataxia, drug ingestion, and the dangerous causes, posterior fossa tumour, cerebellitis, stroke, and central nervous system infection. Chronic or progressive ataxia, evolving over weeks to months, points to the hereditary degenerations, of which Friedreich ataxia is the prototype, and to the metabolic and congenital disorders. The red-flag screen, for headache, vomiting, encephalopathy, focal signs, and a progressive course, is the bridge between the bedside pattern and the imaging decision. [1] [3]
You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship atlas.
References12Show ledgerHide ledger
- [1]Desai J, Mitchell WG Acute cerebellar ataxia, acute cerebellitis, and opsoclonus-myoclonus syndrome. J Child Neurol, 2012.PMID 22805251
- [2]Connolly AM, Dodson WE, Prensky AL, Rust RS Course and outcome of acute cerebellar ataxia. Ann Neurol, 1994.PMID 8210223
- [3]Wilne S, Collier J, Kennedy C, Koller K, Grundy R, Walker D Presentation of childhood CNS tumours: a systematic review and meta-analysis. Lancet Oncol, 2007.PMID 17644483
- [4]Brandão LA, Young Poussaint T Posterior Fossa Tumors. Neuroimaging Clin N Am, 2017.PMID 27889018
- [5]Cook A, Giunti P Friedreich's ataxia: clinical features, pathogenesis and management. Br Med Bull, 2017.PMID 29053830
- [6]Rummey C, Corben LA, Delatycki M, Wilmot G, Mathews K, Subramony SH, et al Natural History of Friedreich Ataxia: Heterogeneity of Neurologic Progression and Consequences for Clinical Trial Design. Neurology, 2022.PMID 35817567
- [7]Lynch DR, Chin MP, Delatycki MB, Subramony SH, Corti M, Hoyle JC, et al Safety and Efficacy of Omaveloxolone in Friedreich Ataxia (MOXIe Study). Ann Neurol, 2021.PMID 33068037
- [8]Rossor T, Yeh EA, Khakoo Y, et al. Diagnosis and Management of Opsoclonus-Myoclonus-Ataxia Syndrome in Children: An International Perspective. Neurol Neuroimmunol Neuroinflamm, 2022.PMID 35260471
- [9]Rothblum-Oviatt C, Wright J, Lefton-Greif MA, McGrath-Morrow SA, Crawford TO, Lederman HM Ataxia telangiectasia: a review. Orphanet J Rare Dis, 2016.PMID 27884168
- [10]Corben LA, Collins V, Milne S, et al. Clinical management guidelines for Friedreich ataxia: best practice in rare diseases. Orphanet J Rare Dis, 2022.PMID 36371255
- [11]Reetz K, Lischewski SA, Dogan I, et al. Friedreich's ataxia-a rare multisystem disease. Lancet Neurol, 2025.PMID 40541211
- [12]Lynch DR, Chin MP, Boesch S, Delatycki MB, Giunti P, Goldsberry A, et al Efficacy of Omaveloxolone in Friedreich's Ataxia: Delayed-Start Analysis of the MOXIe Extension. Mov Disord, 2023.PMID 36444905